| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/07/2011 | CN101647803B External-use medicine for treating burns |
| 09/07/2011 | CN101559215B Skin physiology repair liquid and preparation method thereof |
| 09/07/2011 | CN101543581B Speckle-removing oral liquid |
| 09/07/2011 | CN101530578B Drug for curing skin scratchness |
| 09/07/2011 | CN101524523B External traditional Chinese medicine powder for curing psoriasis |
| 09/07/2011 | CN101513485B Medicament for treating tinea |
| 09/07/2011 | CN101474394B Medicament for rapid healing of incision and knife wound after operation |
| 09/07/2011 | CN101428097B Psoriasis treating Chinese medicine preparation and its preparing process |
| 09/07/2011 | CN101417105B Zedoary turmeric oil glucose injection and preparation method thereof |
| 09/07/2011 | CN101417098B External medicine for treating male and female venereal disease |
| 09/07/2011 | CN101337006B Compound liniment for treating acne |
| 09/07/2011 | CN101274118B Physiotherapy electrode plate clamping self-pasting medicine carrying membrane and manufacture method thereof |
| 09/07/2011 | CN101234103B Total coumarin angelica dahurica composition |
| 09/07/2011 | CN101204507B Tincture medicine for brandy nose |
| 09/07/2011 | CN101185714B Externally-cleaned medicine for treating skin moisture fester |
| 09/07/2011 | CN101120912B Ftibamzone chrisma with PEG-400 as co-solvent |
| 09/07/2011 | CN101090643B Temporally meal menu for infants |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8013017 Dermatological compositions and methods |
| 09/06/2011 | US8013011 Topically applying artemisinine and/or one or more structurally related compounds; dermatomycosis |
| 09/06/2011 | US8012997 Isoindole-imide compounds, compositions, and uses thereof |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012965 e.g. 1-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)-N3-(5,7-ethano-5,7,8-trihydro-6-methyl-1,6-naphthyridin-3-yl)-1H-1,2,4-triazole-3,5-diamine; angiogenesis inhibitor, antiproliferative agent |
| 09/06/2011 | US8012933 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2410025C Use of biguanide derivatives for making a medicine having a wound healing effect |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/06/2011 | CA2364027C Iodine preparation composition |
| 09/05/2011 | CA2733374A1 Novel methods for treating wounds and skin irritations |
| 09/02/2011 | WO2010097344A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/02/2011 | CA2784516A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/01/2011 | WO2011106655A1 Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation |
| 09/01/2011 | WO2011106334A1 Treatment of dermatological allergic conditions |
| 09/01/2011 | WO2011106026A1 Emollient foams for treatment of dermatoses |
| 09/01/2011 | WO2011105839A2 External skin composition and a production method therefor |
| 09/01/2011 | WO2011105657A1 Composition for the prevention or treatment of atopic diseases comprising extract of sophorae tonkinensis radix as active ingredient and method for preparation of the same |
| 09/01/2011 | WO2011105465A1 MAILLARD REACTION INHIBITOR, α-DICARBONYL COMPOUND DECOMPOSING AGENT, AND METHOD FOR INHIBITING THE MAILLARD REACTION |
| 09/01/2011 | WO2011105403A1 Composition having bedsore-relieving effect |
| 09/01/2011 | WO2011104584A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | WO2011104562A1 Fungal nail treatment composition |
| 09/01/2011 | WO2011104490A2 Use of essential oil of oregano and of rosewood, or constituents thereof, in the therapeutic treatment of keratoses |
| 09/01/2011 | WO2011104489A2 Use of essential oil of oregano or of rosewood, or constituents thereof, in the cosmetic treatment of keratoses |
| 09/01/2011 | WO2011104215A1 Biodegradable material containing silicon, for pro-angiogenetic therapy |
| 09/01/2011 | WO2011104214A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 09/01/2011 | WO2011104030A1 Method for promoting the healing of superficial wounds using cells from hair root sheaths, as well as preparation and production method |
| 09/01/2011 | WO2011104029A1 Method for favoring the restoration of a bodily function using hair root sheath cells, preparation and method for production thereof |
| 09/01/2011 | WO2011103648A1 Method for preparing ointments containing antioxidants from polyphenol-rich plants for use in the treatment of wounds of various origins which involve an increase in oxidation-promoting agents and/or increased formation of oxygen-derived reactive species and/or reduced formation of nitric oxide |
| 09/01/2011 | WO2011103624A1 Method of treatment or prevention of hair loss or for the enhancement of hair growth |
| 09/01/2011 | WO2011068303A3 Hyaluronic acid derivative effective against atopic dermatitis, and method for manufacturing same |
| 09/01/2011 | WO2011059866A3 Composition and methods for improving skin appearance |
| 09/01/2011 | WO2011046978A3 Steroidal compounds as melanogenesis modifiers and uses thereof |
| 09/01/2011 | US20110213147 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 09/01/2011 | US20110213033 Skin conditioner |
| 09/01/2011 | US20110213031 Novel type i natural ceramide derivative and method for producing same |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213028 Fatty acid mycophenolate derivatives and their uses |
| 09/01/2011 | US20110213025 Catheter Lock Solutions Utilizing Tocopherol and Mid-Chain Fatty Acids |
| 09/01/2011 | US20110213011 Modulation of smad3 expression |
| 09/01/2011 | US20110213009 Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212988 Tacrolimus preparation for external applications |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212962 P38 map kinase inhibitors |
| 09/01/2011 | US20110212952 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity |
| 09/01/2011 | US20110212951 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212919 Protein cross-linking inhibitor |
| 09/01/2011 | US20110212914 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 09/01/2011 | US20110212905 Crystalline form of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 09/01/2011 | US20110212897 Wnt3a for inhibition of scarring |
| 09/01/2011 | US20110212890 Metastin derivative and use thereof |
| 09/01/2011 | US20110212883 Radical scavenger and active oxygen eliminating agent |
| 09/01/2011 | US20110212882 Uses of kappa opioid synthetic peptide amides |
| 09/01/2011 | US20110212194 Composition for Inhibiting Melanogenesis and Use Thereof |
| 09/01/2011 | US20110212184 Ultra Fine Dead Sea Mineral Compound and Method of Manufacture |
| 09/01/2011 | US20110212170 Formulation For Retinoid-Containing Soft Gelatin Capsules |
| 09/01/2011 | US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended) |
| 09/01/2011 | US20110212167 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| 09/01/2011 | US20110212165 Pharmaceutical compositions of the isolated d-enantiomer of the quinazolinone derivative halofuginone |
| 09/01/2011 | US20110212161 Treatment skin disorders |
| 09/01/2011 | US20110212158 Immunocompatible chorionic membrane products |
| 09/01/2011 | US20110212157 Dermal delivery |
| 09/01/2011 | US20110212150 Process for the treatment of cellulosic molded bones |
| 09/01/2011 | US20110212146 Compositions |
| 09/01/2011 | US20110212136 Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury |
| 09/01/2011 | US20110212099 Methods of modulating il-22 and il-17 |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212093 Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells |
| 09/01/2011 | US20110212077 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 09/01/2011 | US20110212066 Method of fostering the restoration of a body function using cells of the root sheath, composition and preparation method |
| 09/01/2011 | US20110212065 Methods of manufacture of therapeutic products comprising vitalized placental dispersions |
| 09/01/2011 | US20110212064 Therapeutic products comprising vitalized placental dispersions |
| 09/01/2011 | US20110212063 Methods of manufacture of immunocompatible chorionic membrane products |
| 09/01/2011 | US20110212062 Compositions and methods using stem cells in cutaneous wound healing |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |